Comparison of the effects of empagliflozin and glimepiride on endothelial function in patients with type 2 diabetes: A randomized controlled study

Patients with type 2 diabetes who have cardiovascular disease and are receiving empagliflozin have a lower rate of primary composite cardiovascular outcomes. In contrast, glimepiride increases cardiovascular hospitalization when combined with metformin. Here, we assessed the effects of empagliflozin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, Haruka, Kondo, Yoshinobu, Ito, Kohei, Hasebe, Masanori, Satoh, Shinobu, Terauchi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849516/
https://www.ncbi.nlm.nih.gov/pubmed/35171918
http://dx.doi.org/10.1371/journal.pone.0262831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849516/
https://www.ncbi.nlm.nih.gov/pubmed/35171918
http://dx.doi.org/10.1371/journal.pone.0262831

Ejemplares similares